Heart Test Laboratories, Inc. (HSCS)

Market Cap	3.42M
Revenue (ttm)	18,600
Net Income (ttm)	-6.39M
Shares Out	655.62K
EPS (ttm)	-48.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	71,010
Open	5.02
Previous Close	5.10
Day's Range	4.89 - 5.30
52-Week Range	4.89 - 99.00
Beta	3.16
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 17, 2024

About HSCS

Heart Test Laboratories, Inc. d/b/a HeartSciences is a medical technology company focused on applying innovative AI-based technology to an ECG (also known as an EKG) to expand and improve an ECG's clinical utility. Millions of ECGs are performed every week and the Company's objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. HeartSciences has one of the largest libraries of AI-ECG algorithms and is developing AI-ECG solutions to be made availab...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Jun 15, 2022
• Employees: 12
• Stock Exchange: NASDAQ
• Ticker Symbol: HSCS

Financial Performance

In 2023, HSCS's revenue was $5,150, a decrease of -64.17% compared to the previous year's $14,373. Losses were -$6.35 million, 31.6% more than in 2022.